Careers  |  Sign In  |  Register

Latest in Pathology & Lab Medicine

Reuters Health • The Doctor's Channel Daily Newscast

Homocysteine improves cardiovascular risk estimation

NEW YORK (Reuters Health) – Measuring homocysteine improves the accuracy of estimated risk of cardiovascular events, according to an analysis of data from two different sources. “Our observations are novel and demonstrated that elevated homocysteine concentration predicts future CVD (cardiovascular...

Reuters Health • The Doctor's Channel Daily Newscast

Procalcitonin algorithms safely reduce antibiotic use

NEW YORK (Reuters Health) – Algorithms based on procalcitonin (PCT) measurements reduce the use of antibiotics without jeopardizing patient safety, according to a review of randomized clinical trials. Furthermore, the authors of the report in the August 8/22 issue of the Archives of Internal Medicine...

Reuters Health • The Doctor's Channel Daily Newscast

Chemotherapy sensitivity/resistance testing not ready for prime time

NEW YORK (Reuters Health) – No chemotherapy sensitivity and resistance assays have sufficient supporting evidence to justify their use in oncology practice. That’s the conclusion of an American Society of Clinical Oncology (ASCO) panel, reporting in the Journal of Clinical Oncology online July...